|
1
|
Mas VR, Le TH and Maluf DG: Epigenetics in
kidney transplantation: Current evidence, predictions, and future
research directions. Transplantation. 100:23–38. 2016. View Article : Google Scholar
|
|
2
|
Li PK, Burdmann EA and Mehta RL; World
Kidney Day Steering Committee 2013: Acute kidney injury: Global
health alert. Transplantation. 95:653–657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Sandwijk MS, Ten Berge IJ, Majoie CB,
Caan MW, De Sonneville LM, Van Gool WA and Bemelman FJ: Cognitive
changes in chronic kidney disease and after transplantation.
Transplantation. 100:734–742. 2016. View Article : Google Scholar
|
|
4
|
Hakenberg O: Kidney transplantation.
Urologe. 54:13552015.In German. View Article : Google Scholar
|
|
5
|
Verhave J, Boucher A, Dandavino R,
Collette S, Senécal L, Hebert MJ, Girardin C and Cardinal H: The
incidence, management, and evolution of rapamycin-related side
effects in kidney transplant recipients. Clin Transplant.
28:616–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El Ters M, Grande JP, Keddis MT, Rodrigo
E, Chopra B, Dean PG, Stegall MD and Cosio FG: Kidney allograft
survival after acute rejection, the value of follow-up biopsies. Am
J Transplant. 13:2334–2341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vlachopanos G and Georgalis A: On the
value and pitfalls of follow-up biopsies after acute rejection. Am
J Transplant. 14:2372014. View Article : Google Scholar
|
|
8
|
Goldberg RJ, Weng FL and Kandula P: Acute
and chronic allograft dysfunction in kidney transplant recipients.
Med Clin North Am. 100:487–503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Becker LE, Morath C and Suesal C: Immune
mechanisms of acute and chronic rejection. Clin Biochem.
49:320–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwakawa HO and Tomari Y: The Functions of
MicroRNAs: mRNA decay and translational repression. Trends Cell
Biol. 25:651–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan PC, Chen CC, Chen YC, Chang YS and Chu
PH: MicroRNAs in acute kidney injury. Hum Genomics. 10:292016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim JK, Kim TS, Basu J and Jo EK: MicroRNA
in innate immunity and autophagy during mycobacterial infection.
Cell Microbiol. 19:e126872017. View Article : Google Scholar
|
|
17
|
Zawada AM, Zhang L, Emrich IE, Rogacev KS,
Krezdorn N, Rotter B, Fliser D, Devaux Y, et al: MicroRNA profiling
of human intermediate monocytes. Immunobiology. 222:587–596. 2017.
View Article : Google Scholar
|
|
18
|
Oda H, Ikeguchi R, Yurie H, Kaizawa Y,
Ohta S, Yamamoto K, Aoyama T and Matsuda S: Plasma microRNAs are
potential biomarkers of acute rejection after hindlimb
transplantation in rats. Transplantation Direct. 2:e1082016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujino M, Zhu P, Cai S, Nishio Y, Zhuang J
and Li XK: MicroRNAs involved in acute rejection and tolerance in
murine cardiac allografts. Exp Clin Transplant. 14:424–430.
2016.PubMed/NCBI
|
|
20
|
Soltaninejad E, Nicknam MH, Nafar M,
Ahmadpoor P, Pourrezagholi F, Sharbafi MH, Hosseinzadeh M, Foroughi
F, Yekaninejad MS, Bahrami T, et al: Differential expression of
microRNAs in renal transplant patients with acute T-cell mediated
rejection. Transpl Immunol. 33:1–6. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilflingseder J, Reindl-Schwaighofer R,
Sunzenauer J, Kainz A, Heinzel A, Mayer B and Oberbauer R:
MicroRNAs in kidney transplantation. Nephrol Dial Transplant.
30:910–917. 2015. View Article : Google Scholar :
|
|
22
|
Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu
Z and Zhang M: MicroRNA-650 targets ING4 to promote gastric cancer
tumorigenicity. Biochem Biophys Res Commun. 395:275–280. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistance of lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng L, Xie Y, Zhang H and Wu Y:
Down-regulation of NDRG2 gene expression in human colorectal cancer
involves promoter methylation and microRNA-650. Biochem Biophys Res
Commun. 406:534–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zuo ZH, Yu YP, Ding Y, Liu S, Martin A,
Tseng G and Luo JH: Oncogenic activity of miR-650 in prostate
cancer is mediated by suppression of CSR1 expression. Am J Pathol.
185:1991–1999. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chien WW, Domenech C, Catallo R, Kaddar T,
Magaud JP, Salles G and Ffrench M: Cyclin-dependent kinase 1
expression is inhibited by p16(INK4a) at the post-transcriptional
level through the microRNA pathway. Oncogene. 30:1880–1891. 2011.
View Article : Google Scholar
|
|
27
|
Mengel M, Sis B and Halloran PF: SWOT
analysis of Banff: Strengths, weaknesses, opportunities and threats
of the international Banff consensus process and classification
system for renal allograft pathology. Am J Transplant. 7:2221–2226.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Farooqi AA, Qureshi MZ, Coskunpinar E,
Naqvi SK, Yaylim I and Ismail M: MiR-421, miR-155 and miR-650:
Emerging trends of regulation of cancer and apoptosis. Asian Pac J
Cancer Prev. 15:1909–1912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aktaş A: Transplanted kidney function
evaluation. Semin Nucl Med. 44:129–145. 2014. View Article : Google Scholar
|
|
31
|
Montero N, Pérez-Sáez MJ, Pascual J,
Abramowicz D, Budde K, Dudley C, Hazzan M, Klinger M, Maggiore U,
Oberbauer R, et al; DESCARTES Working Group. DESCARTES ERA-EDTA
Board: Immunosuppression in the elderly renal allograft recipient:
A systematic review. Transplant Rev (Orlando). 30:144–153. 2016.
View Article : Google Scholar
|
|
32
|
O'Leary JG, Samaniego M, Barrio MC, Potena
L, Zeevi A, Djamali A and Cozzi E: The influence of
immunosuppressive agents on the risk of de novo donor-specific HLA
antibody production in solid organ transplant recipients.
Transplantation. 100:39–53. 2016. View Article : Google Scholar
|
|
33
|
Watson CJ and Dark JH: Organ
transplantation: Historical perspective and current practice. Br J
Anaesth. 108(Suppl 1): i29–i42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Z, Yang W, Steward N, Sweet SC,
Danziger-Isakov L, Heeger PS and Mohanakumar T: Role of circulating
microRNAs in the immunopathogenesis of rejection following
pediatric lung transplantation. Transplantation. 101:2461–2468.
2017. View Article : Google Scholar
|
|
35
|
Matz M, Lorkowski C, Fabritius K, Durek P,
Wu K, Rudolph B, Neumayer HH, Mashreghi MF and Budde K: Free
microRNA levels in plasma distinguish T-cell mediated rejection
from stable graft function after kidney transplantation. Transpl
Immunol. 39:52–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schmuck RB, Reutzel-Selke A, Raschzok N,
Morgul HM, Struecker B, Lippert S, de Carvalho Fischer C, Schmelzle
M, Boas-Knoop S, Bahra M, et al: Bile: miRNA pattern and
protein-based biomarkers may predict acute cellular rejection after
liver transplantation. Biomarkers. 22:19–27. 2017. View Article : Google Scholar
|
|
37
|
Patnaik S, Mallick R, Kannisto E, Sharma
R, Bshara W, Yendamuri S and Dhillon SS: MiR-205 and MiR-375
microRNA assays to distinguish squamous cell carcinoma from
adenocarcinoma in lung cancer biopsies. J Thorac Oncol. 10:446–453.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wen J, Luo K, Liu H, Liu S, Lin G, Hu Y,
Zhang X, Wang G, Chen Y, Chen Z, et al: MiRNA expression analysis
of pretreatment biopsies predicts the pathological response of
esophageal squamous cell carcinomas to neoadjuvant
chemoradiotherapy. Ann Surg. 263:942–948. 2016. View Article : Google Scholar
|
|
39
|
Gharib SA, Edelman JD, Ge L and Chen P:
Acute cellular rejection elicits distinct microRNA signatures in
airway epithelium of lung transplant patients. Transplant Direct.
1:e442015. View Article : Google Scholar
|
|
40
|
Merhi B, Bayliss G and Gohh RY: Role for
urinary biomarkers in diagnosis of acute rejection in the
transplanted kidney. World J Transplant. 5:251–260. 2015.
View Article : Google Scholar
|
|
41
|
Iwasaki K, Yamamoto T, Inanaga Y,
Hiramitsu T, Miwa Y, Murotani K, Narumi S, Watarai Y, Katayama A,
Uchida K, et al: MiR-142-5p and miR-486-5p as biomarkers for early
detection of chronic antibody-mediated rejection in kidney
transplantation. Biomarkers. 22:45–54. 2017. View Article : Google Scholar
|
|
42
|
Anglicheau D, Sharma VK, Ding R, Hummel A,
Snopkowski C, Dadhania D, Seshan SV and Suthanthiran M: MicroRNA
expression profiles predictive of human renal allograft status.
Proc Natl Acad Sci USA. 106:5330–5335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei Q, Mi QS and Dong Z: The regulation
and function of microRNAs in kidney diseases. IUBMB Life.
65:602–614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ulbing M, Kirsch AH, Leber B, Lemesch S,
Münzker J, Schweighofer N, Hofer D, Trummer O, Rosenkranz AR,
Müller H, et al: MicroRNAs 223-3p and 93-5p in patients with
chronic kidney disease before and after renal transplantation.
Bone. 95:115–123. 2017. View Article : Google Scholar
|
|
45
|
Lorenzen JM, Volkmann I, Fiedler J,
Schmidt M, Scheffner I, Haller H, Gwinner W and Thum T: Urinary
miR-210 as a mediator of acute T-cell mediated rejection in renal
allograft recipients. Am J Transplant. 11:2221–2227. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang IP, Tsai HL, Miao ZF, Huang CW, Kuo
CH, Wu JY, Wang WM, Juo SH and Wang JY: Development of a
deregulating microRNA panel for the detection of early relapse in
postoperative colorectal cancer patients. J Transl Med. 14:1082016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with down-regulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar
|
|
48
|
Kominami R: Role of the transcription
factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser
B Phys Biol Sci. 88:72–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Uddin MN, Zhang Y, Harton JA, MacNamara KC
and Avram D: TNF-alpha-dependent hematopoiesis following Bcl11b
deletion in T cells restricts metastatic melanoma. J Immunol.
192:1946–1953. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mahapatra S, Klee EW, Young CY, Sun Z,
Jimenez RE, Klee GG, Tindall DJ and Donkena KV: Global methylation
profiling for risk prediction of prostate cancer. Clin Cancer Res.
18:2882–2895. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li Z, Chen G, Yang Y, Guo W and Tian W:
Bcl11b regulates enamel matrix protein expression and dental
epithelial cell differentiation during rat tooth development. Mol
Med Rep. 15:297–304. 2017. View Article : Google Scholar
|
|
52
|
Huang X, Chen S, Shen Q, Chen S, Yang L,
Grabarczyk P, Przybylski GK, Schmidt CA and Li Y: Down regulation
of BCL11B expression inhibits proliferation and induces apoptosis
in malignant T cells by BCL11B-935-siRNA. Hematology. 16:236–242.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hirose S, Touma M, Go R, Katsuragi Y,
Sakuraba Y, Gondo Y, Abe M, Sakimura K, Mishima Y and Kominami R:
Bcl11b prevents the intrathymic development of innate CD8 T cells
in a cell intrinsic manner. Int Immunol. 27:205–215. 2015.
View Article : Google Scholar
|
|
54
|
Huang X, Du X and Li Y: The role of BCL11B
in hematological malignancy. Exp Hematol Oncol. 1:222012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang Z, Zhang LJ, Guha G, Li S, Kyrylkova
K, Kioussi C, Leid M, Ganguli-Indra G and Indra AK: Selective
ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic
dermatitis-like skin inflammatory responses in adult mice. PLoS
One. 7:e512622012. View Article : Google Scholar
|
|
56
|
Cherrier T, Le Douce V, Eilebrecht S,
Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M,
Parlakian A, et al: CTIP2 is a negative regulator of P-TEFb. Proc
Natl Acad Sci USA. 110:12655–12660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cismasiu VB, Paskaleva E, Suman Daya S,
Canki M, Duus K and Avram D: BCL11B is a general transcriptional
repressor of the HIV-1 long terminal repeat in T lymphocytes
through recruitment of the NuRD complex. Virology. 380:173–181.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Takachi T, Takahashi M, Takahashi-Yoshita
M, Higuchi M, Obata M, Mishima Y, Okuda S, Tanaka Y, Matsuoka M,
Saitoh A, et al: Human T-cell leukemia virus type 1 Tax oncoprotein
represses the expression of the BCL11B tumor suppressor in T-cells.
Cancer Sci. 106:461–465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li L, Zhang JA, Dose M, Kueh HY, Mosadeghi
R, Gounari F and Rothenberg EV: A far downstream enhancer for
murine Bcl11b controls its T-cell specific expression. Blood.
122:902–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu P, Li P and Burke S: Critical roles of
Bcl11b in T-cell development and maintenance of T-cell identity.
Immunol Rev. 238:138–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kinsey GR and Okusa MD: Expanding role of
T cells in acute kidney injury. Curr Opin Nephrol Hypertens.
23:9–16. 2014. View Article : Google Scholar :
|
|
62
|
Yu Y, Wang C, Clare S, Wang J, Lee SC,
Brandt C, Burke S, Lu L, He D, Jenkins NA, et al: The transcription
factor Bcl11b is specifically expressed in group 2 innate lymphoid
cells and is essential for their development. J Exp Med.
212:865–874. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gutierrez A, Kentsis A, Sanda T, Holmfeldt
L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS,
et al: The BCL11B tumor suppressor is mutated across the major
molecular subtypes of T-cell acute lymphoblastic leukemia. Blood.
118:4169–4173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhong C and Zhu J: Bcl11b drives the birth
of ILC2 innate lymphocytes. J Exp Med. 212:8282015. View Article : Google Scholar : PubMed/NCBI
|
